Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer.

No Thumbnail Available
Date
1998-06-16
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
40 cases postmenopausal women with breast cancer constituted the study group and 20 sex and age matched formed the control group. The study group of untreated patients showed nonsignificant decrease in molybdenum but significant decrease in blood xanthine oxidase and riboflavin levels. Tamoxifen treated patients showed nonsignificant increase in molybdenum, after 3 months, significant increase after 6 months and significant increase in xanthine oxidase and riboflavin levels. Thus tamoxifen when given in breast cancer helps in amelioration of the diseased condition.
Description
Keywords
Citation
Vaidya SM, Kamlakar PL, Kamble SM. Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer. Indian Journal of Medical Sciences. 1998 Jun; 52(6): 244-7
URI
https://imsear.searo.who.int/handle/123456789/68661
Collections
Indian Journal of Medical Sciences